Delivery Order SPE2DB24D2216-SPE2DB25FGNFT
Award Date
3/31/25
Potential Completion Date
4/1/25
Potential Value
$9.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $17,705.55 and a period of performance through February 2025. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMGHX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $3,097.32 and a performance period through January 17, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCRDL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of October 29, 2024 and a ceiling value of $20,678.45. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $1,576.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $2,613.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 7, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, with a ceiling value of $1,744.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MULTAQ 400 MG TABLET 60S, a prescription medication, with a performance period ending on December 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,620.18, is a delivery order for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. It is a firm fixed-price contract, with no set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $11,359.85 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of...
This federal contract award, with an ID of SPE2DB22D2211|SPE2DB25FRSAS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567364205 MULTAQ 400 MG TABLET 60S, with a ceiling value of $24,434.60 and a period of performance through February 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM8T1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $9,745.46. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is February 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...